Safety and short-term efficacy of mirabegron in children with valve bladder: a pilot study
Topic overview
Pilot study evaluating mirabegron therapy in 22 children with valve bladder following posterior urethral valve treatment. Three-month treatment demonstrated significant improvements in voiding frequency, incontinence episodes, urodynamic parameters, and hydronephrosis grade without significant adverse effects.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Safety and short-term efficacy of mirabegron in children with valve bladder: a pilot study. GlobalCastMD Medical Library. 2021-12-02. https://library.globalcastmd.com/article/4717
Comments